News Quantified


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Ocugen (OCGN) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $12.00 price target on the stock.

Why Ocugen (OCGN) Is Up 54.0% After OCU400 Phase 3 Progress And Going Concern Spotlight [Yahoo! Finance]

How Ocugen (OCGN) Phase 2 And Phase 3 Milestones Are Reframing The Investment Story [Yahoo! Finance]

Ocugen spikes as Oppenheimer issues new Outperform on upcoming catalysts [Seeking Alpha]

Oppenheimer Starts Ocugen (OCGN) at Outperform on Gene Therapy Pipeline [Yahoo! Finance]

3/4/2026

08:15 am

ocgn

7.1%

IN-LINE

8/1/2025

08:25 am

ocgn

-4.5%

IN-LINE

5/9/2025

08:01 am

ocgn

-5.6%

BEAT

Oppenheimer Holdings, Inc.

Form 8-K Ocugen, Inc. For: Mar 12

Form 3 Ocugen, Inc. For: Mar 04 Filed by: Johnson-Greene Treerita Essalima

Form S-8 Ocugen, Inc.

Form 10-K Ocugen, Inc. For: Dec 31

Form 8-K Ocugen, Inc. For: Mar 04

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}